Home > Insider Trading > Filing (0001209191-15-081865)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1107421	Ziopharm Oncology Inc	ZIOP	Services-Specialty Outpatient Facilities, Nec (8093)	841475642

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1109753	J Caesar Belbel	C/O Ziopharm Oncology, Inc., One First Ave., Bldg. 34 Boston MA 02129	Coo, Clo, And Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-11-19	153,333	$2.30	212,534	No	4	M	Direct
Common Stock	Disposition	2015-11-19	153,333	$12.84	59,201	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-11-19	153,333	$0.00	153,333	$2.30

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
76,667		2023-06-26	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $12.70 to $12.99, inclusive. The reporting person undertakes to provide to ZIOPHARM Oncology, Inc., any security holder of ZIOPHARM Oncology, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
The option is vested with respect to 153,333 shares; the option vests with respect to the remaining 76,667 shares on 6/27/2016.